A drug against fungal infections in cancer patients can last twice as long in people with obesity, and may make chemotherapy ...

Welcome to the Merck & Company Q3 sales and earnings conference call. [Operator instructions] This call is being recorded.

The company saw strong sales from its top-selling cancer drug Keytruda, recently launched treatments and its animal health ...

On that last point, Merck has increased its payout by a decent 71% in the past five years and offers a dividend yield of 2.8% ...

“We recognize the complexities involved in delivering next-generation therapies to the market. Merck’s EB Grant is designed ...

Merck & Co posted higher-than-expected third-quarter earnings on Thursday on strong sales of its blockbuster cancer treatment ...

Merck, a leading science and technology company, today announced a € 70 million expansion of its ADC manufacturing ...

Merck & Co. is putting down $30 million cash to buy Yale spinout Modifi Biosciences, a deal that includes a preclinical asset ...

Modifi Biosciences, Inc., has announced that the company has been acquired by Merck, known as MSD outside of the United ...

Merck’s acquisition of Modifi Biosciences will give it access to preclinical cancer drug candidates that target DNA repair ...

We recently compiled a list of the 9 Best Dow Stocks to Buy According to Analysts. In this article, we are going to take a ...

In partnership with the Government of Tanzania, the conference celebrates the 7th anniversary of the Merck Foundation’s ...